Gene · 396
Papers1,898
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,898
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ARHGDIB as a prognostic biomarker and modulator of the immunosuppressive microenvironment in glioma. | Cancer Immunol Immunother | 2025 | 40372473 | PubTator, text mining | PubMed |
| Clinical Application of Genetic Testing in Nephrology. | Indian J Nephrol | 2025 | 40352897 | PubTator, text mining | PubMed |
| The biochemical mechanism of Rho GTPase membrane binding, activation and retention in activity patterning. | EMBO J | 2025 | 40164947 | PubTator, text mining | PubMed |
| ClC-5 knockout mitigates angiotensin II-induced hypertension and endothelial dysfunction. | Life Sci | 2025 | 39740756 | PubTator, text mining | PubMed |
| NEK2 Phosphorylates RhoGDI1 to Promote Cell Proliferation, Migration and Invasion Through the Activation of RhoA and Rac1 in Colon Cancer Cells. | Cells | 2024 | 39768163 | PubTator, text mining | PubMed |
| EXPRESSION OF CONCERN: A small molecule, LLL12 inhibits constitutive STAT3 and IL-6-induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells. | FEBS Lett | 2024 | 39394476 | PubTator, text mining | PubMed |
| Rare heterozygous variants in paediatric steroid resistant nephrotic syndrome - a population-based analysis of their significance. | Sci Rep | 2024 | 39127776 | PubTator, text mining | PubMed |
| RhoGDI1 regulates cell-cell junctions in polarized epithelial cells. | Front Cell Dev Biol | 2024 | 39086660 | PubTator, text mining | PubMed |
| Differential gene expression underlying epileptogenicity in patients with gliomas. | Neurooncol Adv | 2024 | 39022648 | PubTator, text mining | PubMed |
| Ultrastructural Characterization of PBMCs and Extracellular Vesicles in Multiple Sclerosis: A Pilot Study. | Int J Mol Sci | 2024 | 38999977 | PubTator, text mining | PubMed |
| P18: Novel Anticancer Peptide from Induced Tumor-Suppressing Cells Targeting Breast Cancer and Bone Metastasis. | Cancers (Basel) | 2024 | 38927935 | PubTator, text mining | PubMed |
| Transient Structural Properties of the Rho GDP-Dissociation Inhibitor. | Angew Chem Int Ed Engl | 2024 | 38853146 | PubTator, text mining | PubMed |
| Neuropathic Corneal Pain: Tear Proteomic and Neuromediator Profiles, Imaging Features, and Clinical Manifestations. | Am J Ophthalmol | 2024 | 38521157 | PubTator, text mining | PubMed |
| Identification of unique genomic signatures in patients with fibromyalgia and chronic pain. | Sci Rep | 2024 | 38366049 | PubTator, text mining | PubMed |
| PLK1 phosphorylates RhoGDI1 and promotes cancer cell migration and invasion. | Cancer Cell Int | 2024 | 38355643 | PubTator, text mining | PubMed |
| Comparative proteomics reveals different protein expression in platelets in patients with alcoholic liver cirrhosis. | Proteome Sci | 2024 | 38279183 | PubTator, text mining | PubMed |
| A complex of cadherin 17 with desmocollin 1 and p120-catenin regulates colorectal cancer migration and invasion according to the cell phenotype. | J Exp Clin Cancer Res | 2024 | 38263178 | PubTator, text mining | PubMed |
| Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling. | Clin Proteomics | 2024 | 38254014 | PubTator, text mining | PubMed |
| RhoGDI phosphorylation by PKC promotes its interaction with death receptor p75NTR to gate axon growth and neuron survival. | EMBO Rep | 2024 | 38253689 | PubTator, text mining | PubMed |
| Molecular Insights into the Breast and Prostate Cancer Cells in Response to the Change of Extracellular Zinc. | J Oncol | 2024 | 38249992 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/396/papers?page=2